The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cruse Michael since 2021.
This trader's CIK number is 1854179.
At the time of last reporting, Cruse Michael was the Chief Operating Officer of Reneo Pharmaceuticals, Inc.. (stock ticker symbol RPHM).
Also see all insider trading activities at Reneo Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | RPHM | 14,755 | $48,675 | 0 | $0 | 0 | $0 |
| 2021 | RPHM | 2,500 | $18,615 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-09-01 | RPHM | Buy | 7,500 | 3.39 | 25,447 |
| 2022-08-31 | RPHM | Buy | 3,212 | 3.21 | 10,307 |
| 2022-08-30 | RPHM | Buy | 2,820 | 3.18 | 8,959 |
| 2022-08-29 | RPHM | Buy | 1,223 | 3.24 | 3,962 |
| 2021-08-25 | RPHM | Buy | 2,500 | 7.45 | 18,615 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cruse Michael (Chief Operating Officer of Reneo Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.